SCHEMBL4924293

SCHEMBL4924293

Cc1cccc(NC(=O)c2ccccc2C(N)=O)c1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.75
KMT2A Q03164 6/20 0.75
ALDH1A1 P00352 2/20 0.75
L3MBTL1 Q9Y468 1/20 0.65
KCNK3 O14649 6/20 0.59
KCNK9 Q9NPC2 6/20 0.59
RXFP1 Q9HBX9 1/20 0.59
SORT1 Q99523 1/20 0.58
SMN1; SMN2 Q16637 2/20 0.56
HSD17B10 Q99714 1/20 0.56
KCNH2 Q12809 1/20 0.55
POLB P06746 1/20 0.55
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
LMNA P02545 2/20 0.55
TP53 P04637 1/20 0.55
MAPT P10636 1/20 0.55
PKM P14618 1/20 0.55
TSHR P16473 1/20 0.55
MAOB P27338 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31194406 0.89 SIRT2 (0.61) MEN1KMT2AALDH1A1KCNK3KCNK9
SCHEMBL3356211 0.86 MEN1 (1.00) MEN1KMT2AALDH1A1L3MBTL1KCNK3
SCHEMBL31424193 0.86 MEN1 (0.72) MEN1KMT2AALDH1A1L3MBTL1KCNK3
SCHEMBL259352 0.86 MEN1 (0.72) MEN1KMT2AALDH1A1L3MBTL1KCNK3
SCHEMBL533767 0.84 KCNK3 (0.81) MEN1KMT2AALDH1A1L3MBTL1KCNK3
SCHEMBL16941525 0.83 MEN1 (0.72) MEN1KMT2AALDH1A1L3MBTL1KCNK3
SCHEMBL10944964 0.82 MEN1 (0.72) MEN1KMT2AALDH1A1L3MBTL1KCNK3
SCHEMBL5742618 0.82 RAB9A (0.68) MEN1KMT2AALDH1A1SMN1; SMN2HSD17B10
SCHEMBL7181742 0.82 MEN1 (0.71) MEN1KMT2AALDH1A1L3MBTL1KCNK3
SCHEMBL1991352 0.81 ALDH1A1 (0.71) MEN1KMT2AALDH1A1SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090863-A1 Pyridine Derivatives and Their Use as Medicaments for Treating Diseases Related to Mch Receptor TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090863-A1 Pyridine Derivatives and Their Use as Medicaments for Treating Diseases Related to Mch Receptor MCHR1, GPR119, MCHR2 MEN1 1056/4885KMT2A 818/4885ALDH1A1 1549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.